IFITM3 and Epstein-Barr virus infection: ZDHHC20 has been reported to enhance the antiviral activity by interferon-induced transmembrane protein 3 (IFITM3), which is worthy of further research on whether it can help people resist EBV infection (McMichael et al., 2017).